# Do GLP-1 Drugs Help With PCOS (PMOS)? What Studies Found | Buy This GLP

What GLP-1 studies found about weight loss, insulin, menstrual cycles and fertility in polyendocrine metabolic ovarian syndrome (PMOS), formerly PCOS.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/do-glp1-drugs-help-pcos
Updated: 2026-11-15
Published: 2026-09-15

[← Research](https://buythisglp.com/research)

Evidence

# Do GLP-1 Drugs Help With PCOS (PMOS)? What Studies Found

GLP-1 medicines may help with weight loss in PCOS. Evidence for menstrual, metabolic and fertility outcomes is more limited.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20265 min readUpdated November 2026

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   GLP-1 drugs may help with short-term weight loss in adults with PCOS and overweight or obesity. There is less certainty about effects on insulin, menstrual cycles and fertility.
-   A UK tirzepatide cohort found similar weight-loss patterns among treated women with and without self-reported PCOS.
-   The international guideline uses the name polyendocrine metabolic ovarian syndrome (PMOS), formerly polycystic ovary syndrome (PCOS).

A May 2026 international consensus adopted the name polyendocrine metabolic ovarian syndrome (PMOS). Many of the studies discussed here use the previous name, polycystic ovary syndrome (PCOS) [\[1\]](https://buythisglp.com/research/do-glp1-drugs-help-pcos#ref-1). Our [review of GLP-1 prescribing records](https://buythisglp.com/research/are-glp1-drugs-prescribed-off-label) includes prescriptions after a PCOS diagnosis. Prescription records and randomized trials answer different questions.

## What randomized studies found

A systematic review of 11 randomized trials found BMI was 1.38 kg/m² lower (95% CI: 0.38 to 2.39 kg/m² lower) with GLP-1 receptor agonists as an add-on treatment, compared with control groups. The authors rated the evidence as low certainty and found too little evidence to draw conclusions about glucose, insulin, excessive hair growth or menstrual regularity [\[2\]](https://buythisglp.com/research/do-glp1-drugs-help-pcos#ref-2).

The [comparison with metformin](https://buythisglp.com/research/is-a-glp1-better-than-metformin-for-pcos) describes the outcomes measured in studies of the two treatments. Check which outcome a study measured before using it to compare treatment options.

In a small open-label randomized trial (n = 64) of women with PCOS-related infertility and overweight or obesity, adding semaglutide to metformin improved menstrual regularity during short follow-up compared with metformin alone [\[3\]](https://buythisglp.com/research/do-glp1-drugs-help-pcos#ref-3). That finding cannot establish a benefit for pregnancy or live birth. The international guideline supports considering anti-obesity medication for higher weight according to general-population guidance and recommends using it for reproductive outcomes only in research settings [\[4\]](https://buythisglp.com/research/do-glp1-drugs-help-pcos#ref-4).

## What the tirzepatide cohort can tell us

Researchers studying [tirzepatide in a UK online weight-management program](https://buythisglp.com/research/tirzepatide-pcos-cohort) reported similar weight-loss trajectories in women with and without self-reported PCOS. Everyone in the comparison received tirzepatide. PCOS status and weight were self-reported, and the study did not measure whether menstrual cycles, androgen symptoms or fertility improved [\[5\]](https://buythisglp.com/research/do-glp1-drugs-help-pcos#ref-5).

Weight management and reproductive care

The guideline advises effective contraception when pregnancy is possible during GLP-1 treatment because pregnancy safety data are limited. If you plan to try to conceive, discuss your medication with your prescriber and fertility team[\[4\]](https://buythisglp.com/research/do-glp1-drugs-help-pcos#ref-4).

## What prescribing records and program fees tell you

In one Polish private health network, the proportion starting an incretin-based medicine within a year of PCOS diagnosis rose from 0.14% in 2018 to 5.97% in 2024. Among incretin users, 11.5% had a coded type 2 diabetes diagnosis. That code alone does not establish the reason for a prescription [\[6\]](https://buythisglp.com/research/do-glp1-drugs-help-pcos#ref-6).

If you are comparing [PCOS Sisters’ GLP-1 management program](https://buythisglp.com/reviews/pcos-sisters) with another form of care, its advertised starting price is $150 per month and membership is required. Ask which membership and pharmacy charges apply to your prescription [\[7\]](https://buythisglp.com/research/do-glp1-drugs-help-pcos#ref-7). If using insurance, the [GLP-1 insurance coverage guide](https://buythisglp.com/research/does-insurance-cover-glp1) explains how a plan can set different rules by product and indication.

## Frequently asked

Are GLP-1 medicines approved to treat PCOS?

PCOS (PMOS) itself is not a U.S. approved indication for these drugs. Some medicines can be prescribed for an approved indication such as chronic weight management or type 2 diabetes when a person meets the relevant criteria.

Can a GLP-1 improve menstrual cycles or fertility in PCOS?

A small trial found more regular cycles when semaglutide was added to metformin. Evidence for fertility outcomes remains uncertain, and the international guideline limits use of anti-obesity medicines for reproductive outcomes to research settings.

Does tirzepatide help with weight loss in people with PCOS?

Women with and without self-reported PCOS had similar recorded weight-loss trajectories in one UK program. The study followed people already taking tirzepatide and did not establish equal effects or improvement in reproductive symptoms.

## Sources

1.  \[1\] Teede HJ, et al. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process The Lancet. [PMID 42119588](https://pubmed.ncbi.nlm.nih.gov/42119588/)
2.  \[2\] Forslund M, et al. (2026). GLP-1 receptor agonist treatment in women with polycystic ovary syndrome: a systematic review and meta-analysis European Journal of Endocrinology. [PMID 41701618](https://pubmed.ncbi.nlm.nih.gov/41701618/)
3.  \[3\] Zhang W, Xue J, Wang A (2026). Semaglutide and metformin improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized trial Metabolism and Target Organ Damage. [Source](https://www.oaepublish.com/articles/mtod.2025.210)
4.  \[4\] International Evidence-Based Guideline development group (2023). International Evidence-based Guideline for the Assessment and Management of Polyendocrine Metabolic Ovarian Syndrome (2026 terminology update) Monash University. [Source](https://www.monash.edu/medicine/mchri/pcos/guideline)
5.  \[5\] Clift AK, et al. (2026). Weight loss outcomes with tirzepatide in women with and without self-reported polycystic ovary syndrome Journal of the Endocrine Society. [PMID 42634795](https://pubmed.ncbi.nlm.nih.gov/42634795/)
6.  \[6\] Dziewierz A, et al. (2026). Temporal Trends and Clinical Characteristics of Incretin-Based Therapy Use in Women With Polycystic Ovary Syndrome: A Real-World Cohort Study From a Polish Private Healthcare Network Diabetes, Obesity and Metabolism. [PMID 42297761](https://doi.org/10.1111/dom.71017)
7.  \[7\] PCOS Sisters (2026). GLP-1 Weight Loss and Metabolic Management PCOS Sisters. [Source](https://pcossisters.com/glp-1-management-for-pcos/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
